American Capital Advisory »

Recursion Pharmaceuticals shares owned by American Capital Advisory

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by American Capital Advisory from 13F filings

Historical chart of American Capital Advisory investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by American Capital Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by American Capital Advisory

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.0k 200 9.86

More positions owned by American Capital Advisory

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Schwab Strategic Tr Sht Tm Us Tres (SCHO)
MGM Resorts International. (MGM)
Dimensional Etf Trust Intl Core Equity (DFIC)
Apple (AAPL)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Markel Corporation (MKL)
Dimensional Etf Trust Us Equity Etf (DFUS)
Cisco Systems (CSCO)
State Street Corporation (STT)
Arcos Dorados Holdings Shs Class -a - (ARCO)
Organon & Co Common Stock (OGN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)

View all positions for American Capital Advisory

Top funds holding Recursion Pharmaceuticals

ARK Investment Management
Baillie Gifford & Co
Vanguard Group
Mubadala Investment Co PJSC
Kinnevik AB
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
MIC Capital Management UK
Nvidia Corp
Norges Bank Investment Management
Dimensional Fund Advisors
Credit Suisse
Point72 Asset Management
Goldman Sachs Group
Charles Schwab Investment Management

View all funds holding Recursion Pharmaceuticals